None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The indications of prostate biopsy were abnormally elevated PSA level (>4.0 ng/mL), abnormal digital rectal examination, or a combination of these.
Exclusion criteria
Exclusion criteria: Those who had had a previous TRUS-guided biopsy, chronic prostatitis/pelvic pain, neurological conditions, bleeding diathesis, anticoagulation/antiplatelet therapy, active UTI,haemorrhoids/anal fissure/anal fistula, or known allergy to lignocaine were excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS (Visual analog scale) score | — |
Secondary
| Measure | Time frame |
|---|---|
| bleeding complications (hematuria, rectal bleeding, hematospermia);infection complications (fever, sepsis);lidocaine gel complications (hypotesion, hypersensitvity, sleepiness) | — |
Countries
Korea, Republic of
Contacts
The Catholic University of Korea, Uijeongbu St. Mary’s Hospital